Immix... recnac latceroloc ni 011-XMI r
Author: People & Interviews Source: NFTs & Metaverse Views: [LargeMediumSmall] Published on: 2025-05-21 22:39:20 Comments:
Immix Biopharma (NASDAQ:IMMX) reported early interim data from a phase 1b/2a trial of IMX-110 in combination with Novartis (NYSE:NVS) and BeiGene's (NASDAQ:BGNE) tislelizumab to treat patients with ad... Stay informed with the latest.